Jazz Pharmaceuticals Plc (JAZZ)

167.50 +2.61 (+1.58%) USD  |  NASDAQ  |  Dec 12, 16:00
167.45 -0.05 (-0.03%) After-Hours: 20:00
More

Jazz Pharmaceuticals Research and Development Expense (TTM): 809.33M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for JAZZ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Zymeworks, Inc. 142.83M
Alkermes Plc 283.30M
Avadel Pharmaceuticals Plc 39.89M
Amarin Corp. Plc 17.36M
Johnson & Johnson 15.77B